2022
DOI: 10.1007/s00423-022-02534-4
|View full text |Cite
|
Sign up to set email alerts
|

Laparoscopic liver resection for colorectal liver metastases: retrospective analysis of prognostic factors and oncological outcomes in a single-center cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…*Clavien-Dindo morbidity classification. 18 †Post Hepatectomy Liver Failure, according to the ISGLS grading system. 19 IQR indicates interquartile range.…”
Section: Oncological Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…*Clavien-Dindo morbidity classification. 18 †Post Hepatectomy Liver Failure, according to the ISGLS grading system. 19 IQR indicates interquartile range.…”
Section: Oncological Resultsmentioning
confidence: 99%
“…A robot-assisted minimally invasive approach for liver surgery was introduced in our center since April 2020. For our standardized approach of minimally invasive liver surgery, we refer to previously published papers 17–20…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…There is evidence that LLR for HCC and CRLM, as well as open hepatectomy (OH) for CRLM and hepatectomy for gastric cancer liver metastases (GCLM), can result in comparable or favorable long-term oncologic outcomes in terms of overall survival and disease-free survival. [22][23][24][25] In some studies, factors such as tumor characteristics, tumor growth pattern, tumor grade, and use of neoadjuvant chemotherapy were found to be associated with worse survival outcomes. 23,25 However, these findings may vary depending on the specific patient population and must be considered in a multidisciplinary treatment setting.…”
Section: Oncologic Outcomesmentioning
confidence: 99%
“…[22][23][24][25] In some studies, factors such as tumor characteristics, tumor growth pattern, tumor grade, and use of neoadjuvant chemotherapy were found to be associated with worse survival outcomes. 23,25 However, these findings may vary depending on the specific patient population and must be considered in a multidisciplinary treatment setting. 25…”
Section: Oncologic Outcomesmentioning
confidence: 99%